258 filings
Page 7 of 13
8-K
92kf6tzs2j3mj
31 Aug 18
Termination of a Material Definitive Agreement
12:00am
8-K
gfy5jt9vaf7sz 2vh
26 Jul 18
Mimedx Announces Receipt of Nasdaq Letter
5:26pm
8-K/A
mxmnj5 swv
11 Jul 18
Departure of Directors or Certain Officers
8:01am
8-K
8m9o3
2 Jul 18
Mimedx Announces Leadership Changes and Corporate Actions
8:03am
8-K/A
au67wg118mrj77i5
25 Jun 18
Financial Statements and Exhibits
4:40pm
8-K
v62qel978m om31
20 Jun 18
Departure of Directors or Certain Officers
4:29pm
8-K/A
tw8htxctey4fq04
12 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K
rvjbgaf7jpci
7 Jun 18
Mimedx to Restate Certain Historical Financial Statements
7:02am
8-K
zpykw kdiqz1ckyr6
18 May 18
MiMedx Receives NASDAQ Notice of Late Form 10-Q Filing
4:31pm
8-K
i0ufj36ii4k6lt
26 Apr 18
Mimedx Reports Unreviewed First Quarter Revenue Exceeds Upper End of Its Guidance
9:06am
8-K
vxngqso
3 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
3pb6zw9c
15 Mar 18
MiMedx Announces Expectation to Exceed the $92 Million
12:00am
8-K
gaf7dq
5 Mar 18
MiMedx Receives Notice of Filing Delinquency from NASDAQ
12:00am
8-K
q8x y55ak
20 Feb 18
MiMedx Postpones Release of its Fourth Quarter and Fiscal Year 2017 Financial Results
12:00am
8-K
xgtkn8tl6rd6 o02ev
8 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
jk04o99tebh1uvrx8lwi
13 Dec 17
Mimedx Forecasts 2018 Revenue to Be In the Range of $383 Million to $387 Million
12:00am
8-K
osj48n tcaod0kl
30 Nov 17
MiMEdx Announces Expectation To Exceed Top End of FOURTH QUARTER Revenue Guidance Of $88 Million
12:00am
8-K
f2j08dnmce9rys4cdfwp
26 Oct 17
Results of Operations and Financial Condition
12:00am
8-K
bzce fbyowbov83hfl
11 Oct 17
Mimedx Announces Third Quarter Revenues of $84.6 Million Exceeds Guidance by More Than 5 Percent
12:00am
8-K
d7524p7js hsrr
5 Oct 17
Mimedx Completes Divestiture of Its
12:00am